Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05836597 · ClinicalTrials.gov registry record · NA

Functional Dyspepsia Treatment Using Virtual Reality

A NA study of Functional Dyspepsia, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05836597 is a NA study of Functional Dyspepsia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 70-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05836597, a NA study of Functional Dyspepsia, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

Conditions Studied

Interventions

  • DEVICE Virtual reality

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-04-01
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05836597

The ClinicalTrials.gov registry entry for NCT05836597 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 70-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (57% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Functional Dyspepsia appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality is the first listed.

NCT05836597 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05836597 about?

NCT05836597 is a clinical study titled "Functional Dyspepsia Treatment Using Virtual Reality". The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

What is the current status of trial NCT05836597?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-01. Estimated completion is 2026-12.

What conditions does trial NCT05836597 study?

This clinical trial studies the following conditions: Functional Dyspepsia.

What interventions are being tested in trial NCT05836597?

The interventions under investigation include: Virtual reality (DEVICE).

Who is sponsoring clinical trial NCT05836597?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05836597 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Functional Dyspepsia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.